Skip to main content
Equibles

NewEdge Advisors, LLC

Position in OCGN — Ocugen, Inc.

CIK 1633516 NEW ORLEANS, LA
Back to OCGN Full portfolio

Position in OCGN

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$362,885
+$61,349 QoQ
Shares Held
237,180
+42.4% QoQ
Ownership
0.070%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#42
of 147 holders
Holding Since
Sep 2023
11 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in OCGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NewEdge Advisors, LLC holds $47,755,733 across 102 Biotechnology names. OCGN ranks #22 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 18,435 $9,157,217
2 REGN
Regeneron Pharmaceuticals, Inc.
 11,911 $7,426,984
3 NUVB
Nuvation Bio Inc.
 1,231,733 $6,996,243
4 INCY
Incyte Corp
 34,605 $3,922,822
5 PHAT
Phathom Pharmaceuticals, Inc.
 203,962 $2,212,987
6 EXEL
Exelixis, Inc.
 32,532 $1,770,066
7 BMRN
Biomarin Pharmaceutical Inc
 27,287 $1,561,362
8 RPRX
Royalty Pharma plc
 21,597 $1,210,943

All Filings in OCGN

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $362,885 237,180
2026-03-31 $301,536 166,595
2025-12-31 $182,871 135,460
2025-09-30 $130,652 80,155
2025-06-30 $35,709 36,814
2025-03-31 $8,721 12,354
2024-12-31 $3 4
2024-06-30 $491 317
2024-03-31 $519 317
2023-12-31 $182 317
2023-09-30 $126 317